@misc{indiciae3e2bb7d676d1,
  title = {APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer},
  author = {Isozaki, H. and Abbasi, A. and Nikpour, N. and Langenbucher, A. and Su, W. and Stanzione, M. and Frisco-Cabanos, H. and Siddiqui, F. M. and Phan, N. and Jalili, P. and Oh, S. and Timonina, D. and Bilton, S. and Gomez-Caraballo, M. and Archibald, H. L. and Nangia, V. and Dionne, K. and Riley, A. and Lawlor, M. and Banwait, M. K. and Cobb, R. G. and Zou, L. and Dyson, N. J. and Ott, C. J. and Benes, C. and Getz, G. and Chan, C. and Shaw, A. T. and Lin, J. J. and Sequist, L. V. and Piotrowska, Z. and Engelman, J. A. and Lee, J. J.-K. and Maruvka, Y. and Buisson, R. and Lawrence, M. S. and Hata, A. N.},
  year = {2021},
  doi = {10.1101/2021.01.20.426852},
  url = {https://www.biorxiv.org/content/10.1101/2021.01.20.426852v1},
  note = {Source identifier: 10.1101/2021.01.20.426852}
}